Xuefeng Leng

P1.071. Perioperative Patient-Reported Outcomes After Robot-Assisted Versus Conventional Minimally Invasive Esophagectomy for Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Analysis

Abstract Topic Esophageal Cancer: Surgical Treatment of Esophageal Cancer – technique Background Robot-assisted minimally invasive esophagectomy (RAMIE) is increasingly adopted, yet comparative patient-reported outcome (PRO) data against conventional minimally invasive esophagect...

P1.066. Prognostic Equivalence of ypN and pN Staging in Esophageal Cancer After Neoadjuvant Therapy: A Multicenter Cohort Study of 2,545 Patients

Abstract Topic Esophageal Cancer: Surgical Treatment of Esophageal Cancer Background Current staging systems apply ypN and pN categories interchangeably after neoadjuvant therapy plus esophagectomy; however, their prognostic equivalence has not been rigorously established. We inv...

P1.070. Exploring the Association Between Month of Esophagectomy and Long-Term Survival Outcomes : a Large-Scale Survival Study Combined Questionnaire Survey Analysis

Abstract Topic Esophageal Cancer: Surgical Treatment of Esophageal Cancer – long term outcomes Background Esophageal cancer remains a significant global health burden. While surgical and oncologic factors influencing survival after esophagectomy are well studied, the potential im...

P1.155. Impact of Lymphaticvessel Invasion on Prognosis in Patients With Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Immunochemotherapy: A Multicenter Retrospective Study

Abstract Topic Esophageal Cancer: Surgical Treatment of Esophageal Cancer Background Prognostic stratification remains inadequate in patients with locally advanced esophageal squamous cell carcinoma (ESCC) following neoadjuvant immunotherapy combined with chemotherapy (NICT). Thi...

P1.063. Development of a Machine Learning-Based Programmed Cell Death Genes Prognostic Model for Esophagea Carcinoma

Abstract Topic Esophageal Cancer: Molecular Biology/Pathology Background To use bioinformatics methods to evaluate the prognostic value of Programmed Cell Death Related Genes (PCDRGs) in esophageal carcinoma (EC), and to explore the development and immune regulatory mechanisms of...